- Home
- OR vs APLS Comparison
OR vs APLS Comparison
Compare OR & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OR
- APLS
- Stock Information
- Founded
- OR 2014
- APLS 2009
- Country
- OR Canada
- APLS United States
- Employees
- OR N/A
- APLS N/A
- Industry
- OR Precious Metals
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- OR Basic Materials
- APLS Health Care
- Exchange
- OR Nasdaq
- APLS Nasdaq
- Market Cap
- OR 3.7B
- APLS 3.3B
- IPO Year
- OR N/A
- APLS 2017
- Fundamental
- Price
- OR $23.33
- APLS $18.20
- Analyst Decision
- OR Strong Buy
- APLS Buy
- Analyst Count
- OR 3
- APLS 18
- Target Price
- OR $23.00
- APLS $45.59
- AVG Volume (30 Days)
- OR 1.1M
- APLS 2.8M
- Earning Date
- OR 05-07-2025
- APLS 05-06-2025
- Dividend Yield
- OR 0.80%
- APLS N/A
- EPS Growth
- OR N/A
- APLS N/A
- EPS
- OR 0.09
- APLS N/A
- Revenue
- OR $191,157,000.00
- APLS $781,367,000.00
- Revenue This Year
- OR $59.27
- APLS $12.71
- Revenue Next Year
- OR $5.45
- APLS $20.93
- P/E Ratio
- OR $267.56
- APLS N/A
- Revenue Growth
- OR 4.33
- APLS 97.02
- 52 Week Low
- OR $15.12
- APLS $17.49
- 52 Week High
- OR $24.07
- APLS $53.06
- Technical
- Relative Strength Index (RSI)
- OR 68.94
- APLS 28.14
- Support Level
- OR $18.99
- APLS $18.00
- Resistance Level
- OR $24.07
- APLS $19.71
- Average True Range (ATR)
- OR 0.96
- APLS 1.63
- MACD
- OR 0.28
- APLS -0.16
- Stochastic Oscillator
- OR 85.45
- APLS 10.98
About OR Osisko Gold Royalties Ltd
Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.